PDS Biotechnology Corp Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
PDS Biotechnology Corp (PDSB) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $151.57 thousand as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-01
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $151.57K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $301.87K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $452.16K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $149.02K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $151.57K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $301.87K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $452.16K 10-Q · filed 2018-05-01 |
| 2017-09-30 | $149.02K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $296.77K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $444.51K 10-Q · filed 2017-05-03 |
| 2016-09-30 | $148.80K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $259.29K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $314.39K 10-Q · filed 2016-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |